Landec Corporation
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of hyaluronate acid (HA) in bulk form, as well as formulated and filled syringes, cartridges, and vials for injectable products used in treating a range of medical conditions and procedures. Its prod… Read more
Landec Corporation (LDE) - Total Liabilities
Latest total liabilities as of August 2025: €245.74 Million EUR
Based on the latest financial reports, Landec Corporation (LDE) has total liabilities worth €245.74 Million EUR as of August 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Landec Corporation - Total Liabilities Trend (2014–2025)
This chart illustrates how Landec Corporation's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Landec Corporation Competitors by Total Liabilities
The table below lists competitors of Landec Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Global Lighting Technologies Inc
TW:4935
|
Taiwan | NT$2.25 Billion |
|
Kewaunee Scientific Corporation
NASDAQ:KEQU
|
USA | $117.36 Million |
|
Polymetals Resources Ltd
AU:POL
|
Australia | AU$78.47 Million |
|
Abion Inc.
KQ:203400
|
Korea | ₩31.76 Billion |
|
Lanna Resources Public Company Limited
BK:LANNA
|
Thailand | ฿3.72 Billion |
|
Richmond International Travel & Tours Co Ltd
TWO:2743
|
Taiwan | NT$2.02 Billion |
Liability Composition Analysis (2014–2025)
This chart breaks down Landec Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.80 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -23.32 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.04 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Landec Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Landec Corporation (2014–2025)
The table below shows the annual total liabilities of Landec Corporation from 2014 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-05-31 | €238.01 Million | -1.91% |
| 2024-05-31 | €242.65 Million | -5.58% |
| 2023-05-31 | €256.99 Million | +37.21% |
| 2022-05-31 | €187.30 Million | -37.60% |
| 2021-05-31 | €300.14 Million | -3.26% |
| 2020-05-31 | €310.27 Million | +24.63% |
| 2019-05-31 | €248.95 Million | +63.63% |
| 2018-05-31 | €152.14 Million | +16.62% |
| 2017-05-31 | €130.46 Million | -0.51% |
| 2016-05-31 | €131.12 Million | +3.77% |
| 2015-05-31 | €126.36 Million | +16.07% |
| 2014-05-31 | €108.86 Million | -- |